Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine use in infants aged 3–6 months with urticaria or eczema
IRCT20110531006660N8Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetirizine in urticaria and atopic dermatitis (AD), sponsored by Mazandaran University of Medical Sciences. Started Apr 2018; status: completed.
02
Drugs
cetirizine
03
Conditions
urticariaatopic dermatitis (AD)
Beyond the preview
Go deeper on IRCT20110531006660N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110531006660N8.